{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:55:55Z","timestamp":1789480555343,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03236-5","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:52:03Z","timestamp":1762959123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanism of methyltransferase METTL14 mediating m6A modification and regulating SIRT5 expression to promote ferroptosis and repress gastric cancer progression"],"prefix":"10.1186","volume":"30","author":[{"given":"Haoruo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9152-5743","authenticated-orcid":false,"given":"Kaiqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"2","key":"3236_CR1","first-page":"87","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"3236_CR2","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.6004\/jnccn.2016.0137","volume":"14","author":"JA Ajani","year":"2016","unstructured":"Ajani JA, D\u2019Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, et al. Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2016;14(10):1286\u2013312.","journal-title":"J Natl Compr Canc Netw"},{"issue":"9742","key":"3236_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687\u201397.","journal-title":"Lancet"},{"issue":"10","key":"3236_CR4","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa010187","volume":"345","author":"JS Macdonald","year":"2001","unstructured":"Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725\u201330.","journal-title":"N Engl J Med"},{"issue":"18","key":"3236_CR5","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810\u201320.","journal-title":"N Engl J Med"},{"key":"3236_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/1477-3163.146506","volume":"13","author":"LP Carcas","year":"2014","unstructured":"Carcas LP. Gastric cancer review. J Carcinog. 2014;13:14.","journal-title":"J Carcinog"},{"issue":"5","key":"3236_CR7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"3","key":"3236_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23(3):369\u201379.","journal-title":"Cell Death Differ"},{"key":"3236_CR9","doi-asserted-by":"crossref","unstructured":"Xu X, Lai Y, Hua ZC. Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci Rep. 2019;39(1):BSR20180992.","DOI":"10.1042\/BSR20180992"},{"key":"3236_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2018.09.043","volume":"133","author":"T Hirschhorn","year":"2019","unstructured":"Hirschhorn T, Stockwell BR. The development of the concept of ferroptosis. Free Radic Biol Med. 2019;133:130\u201343.","journal-title":"Free Radic Biol Med"},{"issue":"51","key":"3236_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201904197","volume":"31","author":"C Liang","year":"2019","unstructured":"Liang C, Zhang X, Yang M, Dong X. Recent progress in ferroptosis inducers for cancer therapy. Adv Mater. 2019;31(51):e1904197.","journal-title":"Adv Mater"},{"issue":"4","key":"3236_CR12","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.7150\/ijbs.80324","volume":"19","author":"C Hu","year":"2023","unstructured":"Hu C, Zu D, Xu J, Xu H, Yuan L, Chen J, et al. Polyphyllin B suppresses gastric tumor growth by modulating iron metabolism and inducing ferroptosis. Int J Biol Sci. 2023;19(4):1063\u201379.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"3236_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41388-022-02537-x","volume":"42","author":"D Li","year":"2023","unstructured":"Li D, Wang Y, Dong C, Chen T, Dong A, Ren J, et al. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene. 2023;42(2):83\u201398.","journal-title":"Oncogene"},{"key":"3236_CR14","doi-asserted-by":"publisher","first-page":"1145407","DOI":"10.3389\/fphar.2023.1145407","volume":"14","author":"F Zheng","year":"2023","unstructured":"Zheng F, Wang Y, Zhang Q, Chen Q, Liang CL, Liu H, et al. Polyphyllin i suppresses the gastric cancer growth by promoting cancer cell ferroptosis. Front Pharmacol. 2023;14:1145407.","journal-title":"Front Pharmacol"},{"key":"3236_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154646","volume":"248","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Cui J, Cui M, Jing R. Slc7a11 promotes the progression of gastric cancer and regulates ferroptosis through PI3K\/AKT pathway. Pathol Res Pract. 2023;248:154646.","journal-title":"Pathol Res Pract"},{"key":"3236_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.902302","volume":"13","author":"L Lu","year":"2022","unstructured":"Lu L, Chen B, Xu Y, Zhang X, Jin L, Qian H, et al. Role of ferroptosis and ferroptosis-related non-coding RNAs in the occurrence and development of gastric cancer. Front Pharmacol. 2022;13:902302.","journal-title":"Front Pharmacol"},{"issue":"10","key":"3236_CR17","doi-asserted-by":"publisher","first-page":"4630","DOI":"10.1111\/jcmm.13804","volume":"22","author":"L He","year":"2018","unstructured":"He L, Li J, Wang X, Ying Y, Xie H, Yan H, et al. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers. J Cell Mol Med. 2018;22(10):4630\u20139.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"3236_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23655","volume":"35","author":"X Liu","year":"2021","unstructured":"Liu X, Xiao M, Zhang L, Li L, Zhu G, Shen E, et al. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K\/AKT\/mTOR signaling pathway. J Clin Lab Anal. 2021;35(3):e23655.","journal-title":"J Clin Lab Anal"},{"issue":"9","key":"3236_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/stcltm\/szac049","volume":"11","author":"M He","year":"2022","unstructured":"He M, Lei H, He X, Liu Y, Wang A, Ren Z, et al. METTL14 regulates osteogenesis of bone marrow mesenchymal stem cells via inducing autophagy through m6A\/IGF2BPs\/Beclin-1 signal axis. Stem Cells Transl Med. 2022;11(9):987\u20131001.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"3236_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13020-023-00820-x","volume":"18","author":"F Wang","year":"2023","unstructured":"Wang F, Sun Z, Zhang Q, Yang H, Yang G, Yang Q, et al. Curdione induces ferroptosis mediated by m6A methylation via METTL14 and YTHDF2 in colorectal cancer. Chin Med. 2023;18(1):122.","journal-title":"Chin Med"},{"issue":"36","key":"3236_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303812","volume":"10","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang C, Guan X, Ma Y, Zhang S, Li F, et al. PRMT3-mediated arginine methylation of METTL14 promotes malignant progression and treatment resistance in endometrial carcinoma. Adv Sci (Weinh). 2023;10(36):e2303812.","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"3236_CR22","doi-asserted-by":"publisher","first-page":"300060520986355","DOI":"10.1177\/0300060520986355","volume":"49","author":"W Gu","year":"2021","unstructured":"Gu W, Qian Q, Xu Y, Xu X, Zhang L, He S, et al. SIRT5 regulates autophagy and apoptosis in gastric cancer cells. J Int Med Res. 2021;49(2):300060520986355.","journal-title":"J Int Med Res"},{"issue":"2","key":"3236_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.06.028","volume":"382","author":"X Lu","year":"2019","unstructured":"Lu X, Yang P, Zhao X, Jiang M, Hu S, Ouyang Y, et al. Ogdh mediates the inhibition of SIRT5 on cell proliferation and migration of gastric cancer. Exp Cell Res. 2019;382(2):111483.","journal-title":"Exp Cell Res"},{"issue":"8","key":"3236_CR24","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1111\/cas.13691","volume":"109","author":"Z Tang","year":"2018","unstructured":"Tang Z, Li L, Tang Y, Xie D, Wu K, Wei W, et al. CDK2 positively regulates aerobic glycolysis by suppressing SIRT5 in gastric cancer. Cancer Sci. 2018;109(8):2590\u20138.","journal-title":"Cancer Sci"},{"issue":"7","key":"3236_CR25","first-page":"3357","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen J, Zhao F, Yang H, Wen J, Tang Y, Wan F, et al. Gentian violet induces apoptosis and ferroptosis via modulating p53 and MDM2 in hepatocellular carcinoma. Am J Cancer Res. 2022;12(7):3357\u201372.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"3236_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57.","journal-title":"J Hematol Oncol"},{"issue":"11","key":"3236_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32014","volume":"10","author":"X Zhao","year":"2024","unstructured":"Zhao X, Lu J, Wu W, Li J. METTL14 inhibits the malignant processes of gastric cancer cells by promoting N6-methyladenosine (m6A) methylation of TAF10. Heliyon. 2024;10(11):e32014.","journal-title":"Heliyon"},{"issue":"1","key":"3236_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12943-022-01634-5","volume":"21","author":"B Shi","year":"2022","unstructured":"Shi B, Liu WW, Yang K, Jiang GM, Wang H. The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer. Mol Cancer. 2022;21(1):163.","journal-title":"Mol Cancer"},{"issue":"1","key":"3236_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-020-1146-4","volume":"19","author":"X Yang","year":"2020","unstructured":"Yang X, Zhang S, He C, Xue P, Zhang L, He Z, et al. Mettl14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST. Mol Cancer. 2020;19(1):46.","journal-title":"Mol Cancer"},{"issue":"1","key":"3236_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12943-019-1084-1","volume":"18","author":"C Gu","year":"2019","unstructured":"Gu C, Wang Z, Zhou N, Li G, Kou Y, Luo Y, et al. Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N(6)-methyladenosine of Notch1. Mol Cancer. 2019;18(1):168.","journal-title":"Mol Cancer"},{"key":"3236_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.578963","volume":"10","author":"PJ Gong","year":"2020","unstructured":"Gong PJ, Shao YC, Yang Y, Song WJ, He X, Zeng YF, et al. Analysis of N6-methyladenosine methyltransferase reveals METTL14 and ZC3H13 as tumor suppressor genes in breast cancer. Front Oncol. 2020;10:578963.","journal-title":"Front Oncol"},{"issue":"8","key":"3236_CR32","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.7150\/jca.82158","volume":"14","author":"CL Sun","year":"2023","unstructured":"Sun CL, Chen J, Xing ZW, Tao GS. METTL14 suppresses cancer stem cell phenotype of colorectal cancer via regulating of beta-catenin\/NANOG. J Cancer. 2023;14(8):1407\u201316.","journal-title":"J Cancer"},{"issue":"1","key":"3236_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12943-019-1033-z","volume":"18","author":"XY Chen","year":"2019","unstructured":"Chen XY, Zhang J, Zhu JS. The role of m(6)A RNA methylation in human cancer. Mol Cancer. 2019;18(1):103.","journal-title":"Mol Cancer"},{"issue":"2","key":"3236_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jhep.2022.02.030","volume":"77","author":"R Sun","year":"2022","unstructured":"Sun R, Zhang Z, Bao R, Guo X, Gu Y, Yang W, et al. Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis. J Hepatol. 2022;77(2):453\u201366.","journal-title":"J Hepatol"},{"issue":"5","key":"3236_CR35","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1053\/j.gastro.2021.06.045","volume":"161","author":"T Hu","year":"2021","unstructured":"Hu T, Shukla SK, Vernucci E, He C, Wang D, King RJ, et al. Metabolic rewiring by loss of Sirt5 promotes Kras-induced pancreatic cancer progression. Gastroenterology. 2021;161(5):1584\u2013600.","journal-title":"Gastroenterology"},{"issue":"1","key":"3236_CR36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/imr.13280","volume":"321","author":"J Le","year":"2024","unstructured":"Le J, Pan G, Zhang C, Chen Y, Tiwari AK, Qin JJ. Targeting ferroptosis in gastric cancer: strategies and opportunities. Immunol Rev. 2024;321(1):228\u201345.","journal-title":"Immunol Rev"},{"issue":"1","key":"3236_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D, et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020;19(1):43.","journal-title":"Mol Cancer"},{"issue":"11","key":"3236_CR38","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1038\/s41418-022-01008-w","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zheng L, Shang W, Yang Z, Li T, Liu F, et al. Wnt\/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer. Cell Death Differ. 2022;29(11):2190\u2013202.","journal-title":"Cell Death Differ"},{"issue":"4","key":"3236_CR39","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/s11064-023-04095-4","volume":"49","author":"J Li","year":"2024","unstructured":"Li J, Wei G, Song Z, Chen Z, Gu J, Zhang L, et al. SIRT5 regulates ferroptosis through the Nrf2\/HO-1 signaling axis to participate in ischemia-reperfusion injury in ischemic stroke. Neurochem Res. 2024;49(4):998\u20131007.","journal-title":"Neurochem Res"},{"issue":"1","key":"3236_CR40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41419-025-07626-9","volume":"16","author":"T Wang","year":"2025","unstructured":"Wang T, Han XH, Chen JJ, Wang X, Zhang Z, Han XJ, et al. SIRT5-mediated BCAT1 desuccinylation and stabilization leads to ferroptosis insensitivity and promotes cell proliferation in glioma. Cell Death Dis. 2025;16(1):261.","journal-title":"Cell Death Dis"},{"issue":"3","key":"3236_CR41","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s10565-021-09660-7","volume":"39","author":"S Zhuang","year":"2023","unstructured":"Zhuang S, Ma Y, Zeng Y, Lu C, Yang F, Jiang N, et al. METTL14 promotes doxorubicin-induced cardiomyocyte ferroptosis by regulating the KCNQ1OT1-miR-7-5p-TFRC axis. Cell Biol Toxicol. 2023;39(3):1015\u201335.","journal-title":"Cell Biol Toxicol"},{"issue":"1","key":"3236_CR42","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12943-020-01220-7","volume":"19","author":"X Chen","year":"2020","unstructured":"Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B, et al. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer. 2020;19(1):106.","journal-title":"Mol Cancer"},{"issue":"10","key":"3236_CR43","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/s41587-023-01676-0","volume":"41","author":"Y Liu","year":"2023","unstructured":"Liu Y, DiStasio M, Su G, Asashima H, Enninful A, Qin X, et al. High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial CITE-seq. Nat Biotechnol. 2023;41(10):1405\u20139.","journal-title":"Nat Biotechnol"},{"key":"3236_CR44","first-page":"3","volume":"1","author":"R Fan","year":"2024","unstructured":"Fan R, Zhang D, Rodriguez-Kirby L, Lin Y, Song M, Wang L, et al. Spatial dynamics of mammalian brain development and neuroinflammation by multimodal tri-omics mapping. Res Sq. 2024;1:3.","journal-title":"Res Sq"},{"key":"3236_CR45","first-page":"3","volume":"8","author":"R Fan","year":"2025","unstructured":"Fan R, Baysoy A, Tian X, Zhang F, Renauer P, Bai Z, et al. Spatially Resolved Panoramic in vivo CRISPR Screen via Perturb-DBiT. Res Sq. 2025;8:3.","journal-title":"Res Sq."}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03236-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03236-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03236-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T16:03:06Z","timestamp":1762963386000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03236-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3236"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03236-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Academic Ethics Committee of Shanxi Province Cancer Hospital\/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences\/Cancer Hospital Affiliated to Shanxi Medical University and conducted in strict accordance with the regulations for laboratory animal management and use. Efforts were made to minimize the number of animals used and to reduce their sufferings.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1115"}}